Guía OncoSur de SARCOMAS de partes blandas

Guía OncoSur de sarcomas de partes blandas

BIBLIOGRAFÍA

1. DeVita V, Hellman, Rosenberg S. Cancer: principles and practice of oncology. 10

ed. Wolters Kluwer Health/

Lippincott Williams and Wilkins; 2015.

2. Martín-Broto J, Cruz J, Valverde C, et al. Tratado de sarcoma de partes blandas. 1.ª ed. Madrid: Nature Publish-

ing Group Iberoamerica; 2015.

3. Ravi V, Patel S. Adjuvant chemotherapy for soft tissue sarcomas. Surg Oncol Clin N Am 2012;21(2):243-53.

4. Gronchi A, Casali PG. Adjuvant therapy for high-risk soft tissue sarcoma in the adult. Curr Treat Options Oncol

2013;14(3):415-24.

5. Frustaci S, Gherlinzoni F, De Paoli A, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extrem-

ities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol 2001;1;19(5):1238-47.

6. Bajpai J, Susan D. Adjuvant chemotherapy in soft tissue sarcomas... Conflicts, consensus, and controversies.

South Asian J Cancer 2016;5(1):15-9.

7. García del Muro X, de Álava E, Artigas V, et al. Clinical practice guidelines for the diagnosis and treatment

of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS). Cancer Chemother

Pharmacol 2016 Jan;77(1):133-46.

8. ESMO/European Sarcoma Network Working Group. Soft tissue and visceral sarcomas: ESMO Clinical Practice

Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2014;25(Suppl 3):iii102-12.

9. Nathenson MJ, Sausville E. Looking for answers: the current status of neoadjuvant treatment in localized soft

tissue sarcomas. Cancer Chemother Pharmacol 2016;78(5):895-919.

10. Gronchi A, Stacchiotti S, Verderio P, et al. Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft

tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and

the Spanish Sarcoma Group. Ann Oncol 2016; Oct 11.

11. Ratan R, Patel SR. Chemotherapy for soft tissue sarcoma. Cancer 2016;122(19):2952-60.

12. Gronchi A, Ferrari S, Quagliuolo V, et at. LBA6_PR - Full-dose neoadjuvant anthracycline + ifosfamide chemo-

therapy is associated with a relapse free survival (RFS) and overall survival (OS) benefit in localized high-risk

adult soft tissue sarcomas (STS) of the extremities and trunk wall: Interim analysis of a prospective randomized

trial. Viena: ESMO;2016.